Literature DB >> 29479237

Amphetamines for attention deficit hyperactivity disorder in children and adolescents.

Mark E Feldman1.   

Abstract

Entities:  

Year:  2017        PMID： 29479237      PMCID： PMC5804922          DOI： 10.1093/pch/pxx084

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  10 in total

1.  Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study.

Authors:  Søren Dalsgaard; Søren Dinesen Østergaard; James F Leckman; Preben Bo Mortensen; Marianne Giørtz Pedersen
Journal:  Lancet       Date:  2015-02-26       Impact factor: 79.321

2.  Extended-release medications for children and adolescents with attention-deficit hyperactivity disorder.

Authors:  M Feldman; S Bélanger
Journal:  Paediatr Child Health       Date:  2009-11       Impact factor: 2.253

3.  Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients.

Authors:  Anne Halmøy; Ole Bernt Fasmer; Christopher Gillberg; Jan Haavik
Journal:  J Atten Disord       Date:  2009-04-16       Impact factor: 3.256

4.  Functional impairment and occupational outcome in adults with ADHD.

Authors:  Bjørn Gjervan; Terje Torgersen; Hans M Nordahl; Kirsten Rasmussen
Journal:  J Atten Disord       Date:  2011-07-01       Impact factor: 3.256

5.  A population-based study of stimulant drug treatment of ADHD and academic progress in children.

Authors:  Helga Zoëga; Kenneth J Rothman; Krista F Huybrechts; Örn Ólafsson; Gísli Baldursson; Anna B Almarsdóttir; Sólveig Jónsdóttir; Matthías Halldórsson; Sonia Hernández-Diaz; Unnur A Valdimarsdóttir
Journal:  Pediatrics       Date:  2012-06-25       Impact factor: 7.124

6.  Effect of methylphenidate formulation on treatment patterns and use of emergency room services.

Authors:  Jason E Kemner; Maureen J Lage
Journal:  Am J Health Syst Pharm       Date:  2006-02-15       Impact factor: 2.637

7.  Positive association between attention-deficit/ hyperactivity disorder medication use and academic achievement during elementary school.

Authors:  Richard M Scheffler; Timothy T Brown; Brent D Fulton; Stephen P Hinshaw; Peter Levine; Susan Stone
Journal:  Pediatrics       Date:  2009-05       Impact factor: 7.124

8.  Methylphenidate for ADHD in children and adolescents: throwing the baby out with the bathwater.

Authors:  Tobias Banaschewski; Jan Buitelaar; Celine S L Chui; David Coghill; Samuele Cortese; Emily Simonoff; Ian C K Wong
Journal:  Evid Based Ment Health       Date:  2016-10-06

9.  Medication for attention deficit-hyperactivity disorder and criminality.

Authors:  Paul Lichtenstein; Linda Halldner; Johan Zetterqvist; Arvid Sjölander; Eva Serlachius; Seena Fazel; Niklas Långström; Henrik Larsson
Journal:  N Engl J Med       Date:  2012-11-22       Impact factor: 91.245

Review 10.  Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.

Authors:  Ole Jakob Storebø; Helle B Krogh; Erica Ramstad; Carlos R Moreira-Maia; Mathilde Holmskov; Maria Skoog; Trine Danvad Nilausen; Frederik L Magnusson; Morris Zwi; Donna Gillies; Susanne Rosendal; Camilla Groth; Kirsten Buch Rasmussen; Dorothy Gauci; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  BMJ       Date:  2015-11-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.